A bitter pill: GSK on the defensive as pharma probe deepens
Also: Wahaha in the firing line over Russian rye drink; weibo attack reignites China Resources coal row; and central bank takes next steps in interest rate reform
Plus: Abe election win perturbs Chinese press; chengguan blamed for melon farmer murder; and how Poly prospered from arms-to-apartments switch